Other languages Peijia Medical Limited

Equities

9996

KYG6981F1090

Market Closed - Hong Kong S.E. Other stock markets 08:08:03 28/03/2024 GMT			5-day change	1st Jan Change
3.66 ^HKD	-3.94%		-.--%	-50.47%

04-08	JenaValve Technology, Inc. announced that it has received $100.4 million in funding from a group of investors	CI
04-02	Peijia Medical Limited Delays in Publication of 2023 Annual Results	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Peijia Medical Limited Delays in Publication of 2023 Annual Results	04-02
Peijia Medical Narrows 2023 Loss as Revenue Jumps 76%	04-01
Peijia Medical Limited Reports Earnings Results for the Full Year Ended December 31, 2023	03-28
Peijia Medical Announces Successful Completion of Patient Enrollment for Pivotal TaurusTrio Transcatheter Aortic Regurgitation Clinical Trial	01-29
Peijia Medical's 2023 Profit to Jump Up to 79.4%	01-26
Peijia Medical Limited Reports Earnings Results for the Half Year Ended June 30, 2023	31/08/23
Peijia Medical Limited Announces First Patient in Multi-Center Registration Clinical Trial of Taurustrio?? Transcatheter Aortic Valve Replacement System in China	31/07/23
Peijia Medical Limited Provides Unaudited Revenue Guidance for the Period from January 1, 2023 to June 30, 2023	21/07/23
Peijia Medical Limited Receives Approval from the National Medical Products Administration of the PRC for the Registration Application of DCwireTM Micro Guidewire	06/07/23
Peijia Medical's 2022 Loss Narrows 29%	03/04/23
Peijia Medical Limited Reports Earnings Results for the Full Year Ended December 31, 2022	31/03/23
Peijia Medical's 2022 Revenue Surges Up to 90.4%	18/01/23
Peijia Medical Limited Announces First Patient Enrollment in the Multi-Center Registration Clinical Trial of Geminione Transcatheter Edge-To-Edge Repair System in China	04/12/22
Peijia Medical Limited Announces in Partnership with inQB8 Medical Technologies, LLC Successfully Completed the First Patient Implant in the First-In-Man Clinical Trial of the MonarQ Transcatheter Tricuspid Valve Replacement System in the World	24/11/22
Peijia Medical Limited Announces First Patient Implant in Multi-Center Registrationclinical Trial of Peijia Highlife Transcatheter Mitralvalve Replacement System in China	14/11/22
Peijia Medical's H1 Net Loss Narrows 47.5%	22/08/22
Peijia Medical Limited Reports Earnings Results for the Half Year Ended June 30, 2022	19/08/22
Peijia Medical Limited Announces Executive Changes	17/06/22
Peijia Medical Limited Receives NMPA Approval for Registration Application of Fluxcap Balloon Guide Catheter	08/06/22
Peijia Medical Limited Receives NMPA Approval for Registration Application of Fastunnel Delivery Balloon Dilation Catheter	22/05/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Peijia Medical Limited

Equities

9996

KYG6981F1090

Other languages

Filters